On October 21, 2019, during UEG week held in Barcelona, ABIVAX has reported Impressive 12-month Efficacy and Safety Data from ABX464 Ulcerative Colitis Maintenance Study.
Information is available at the following link: https://www.abivax.com/investors/ueg-week-2019/
LifeSci Capital Alpha Series:Adam Evertts & David Sherman
Bryan, Garnier & Co:Eric Le Berrigaud & Jean-Jacques Le Fur
- Contact Eric Le Berrigaud
- Contact Jean-Jacques Le Fur
- Bryan, Garnier & Co analyst report executive summary